Semaglutide and Tirzepatide function by activating GLP-1 and GIP receptors, which are crucial in controlling blood sugar and appetite
The prevalence of keratinocytes IR receptors and associated genetic receptor mutations may also partially cause this imbalance to occur
Apperloo EM, Neuen BL, Fletcher RA, et al
These medications may support weight loss, improve insulin resistance, and even lead to Read More
Has the sensitivity stayed the same, improved, or worsened
These include supports beyond the medication, such as: Behavioral therapy Group counseling Residential treatment Lifestyle adjustments that foster sustainable well-being Since GLP-1 impacts brain circuits related to addiction, Semaglutide might be especially beneficial for patients with both obesity and substance use disorders, where these systems may not work correctly